CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
CERo Therapeutics is continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
- Go to the previous page
- 1
- …
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- …
- 325
- Go to the next page